CANNELL CAPITAL LLC - 09 Jan 2023 Form 4 Insider Report for Neuronetics, Inc. (STIM)

Role
10%+ Owner
Signature
Nichole Rousseau-McAllister
Issuer symbol
STIM
Transactions as of
09 Jan 2023
Net transactions value
-$1,346,760
Form type
4
Filing time
13 Jan 2023, 16:32:03 UTC
Previous filing
06 Jan 2023
Next filing
19 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STIM Neuronetics, Inc. Ordinary Stock Sale $933,566 -141,664 -4.5% $6.59 3,005,389 09 Jan 2023 By partnerships and separately-managed accounts F1, F2
transaction STIM Neuronetics, Inc. Ordinary Stock Sale $246,392 -36,885 -1.2% $6.68 2,968,504 10 Jan 2023 By partnerships and separately-managed accounts F1, F2
transaction STIM Neuronetics, Inc. Ordinary Stock Sale $57,856 -8,970 -0.3% $6.45 2,959,534 11 Jan 2023 By partnerships and separately-managed accounts F1, F2
transaction STIM Neuronetics, Inc. Ordinary Stock Sale $78,101 -12,397 -0.42% $6.30 2,947,137 12 Jan 2023 By partnerships and separately-managed accounts F1, F2
transaction STIM Neuronetics, Inc. Ordinary Stock Sale $30,845 -4,896 -0.17% $6.30 2,942,241 13 Jan 2023 By partnerships and separately-managed accounts F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of January 13, 2023, Tonga Partners, LP, Tristan Partners, LP, and Tristan Offshore Fund, Ltd., and sundry separately-managed accounts advised by Cannell Capital LLC (collectively the "Cannell Investment Vehicles") owned in the aggregate 2,942,241 shares of the common stock of Neuronetics, Inc.
F2 Cannell Capital LLC acts as the general partner of and investment adviser to Tonga Partners, LP, and Tristan Partners, L.P. and as the investment adviser to the Tristan Offshore Fund, Ltd and the sundry separately-managed accounts. J. Carlo Cannell is the sole managing member of Cannell Capital LLC. As such, Mr. Cannell possesses sole power to vote and direct the disposition of all securities of Neuronetics, Inc. held by the Cannell Investment Vehicles. Thus, for the purposes of Reg. Section 240.13d-3, as of January 13, 2023, Mr. Cannell beneficially owned 2,942,241 shares. Mr. Cannell's interest in the securities reported herein is limited to the extent of his pecuniary interest in each of the Cannell Investment Vehicles, if any.